No Data
No Data
Express News | Protalix BioTherapeutics Shares Are Trading Lower After the Company Reported Worse-than-expected Q2 EPS Results
Protalix BioTherapeutics, Inc. (PLX) Q2 2024 Earnings Call Transcript Summary
Protalix BioTherapeutics Q2 24 Earnings Conference Call At 8:30 AM ET
Protalix Biotherapeutics | 10-Q: Q2 2024 Earnings Report
Express News | Protalix BioTherapeutics Q2 2024 GAAP EPS $(0.03) Misses $0.02 Estimate, Sales $13.474M Beat $12.500M Estimate
Earnings Flash (PLX) PROTALIX BIOTHERAPEUTICS Reports Q2 Revenue $13.5M, Vs. Street Est of $12.5M
No Data